Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study
Kerri Beckmann, Hans Garmo, Bertil Lindahl, Lars Holmberg, Pär Stattin, Jan Adolfsson, J. CRUICKSHANK, Mieke Van Hemelrijck
Topics & Concepts
SpironolactoneMedicineOdds ratioProstate cancerPopulationInternal medicineConfidence intervalCase-control studyDiureticUrologyCancerHeart failureEnvironmental healthHormonal Regulation and HypertensionHormonal and reproductive studiesProstate Cancer Treatment and Research